home

US News topics

headline news | recent news | latest news | market news | recent topics | stock topics

Country: US | UK | AU | HK | SG | MY

Market news - chevrons indicate local prediction, arrows show global predictions, circles show importance
Local topics
Nevada launches contact tracing app to anonymously alert of possible COVID-19 exposures - carsonnow org
CZR    - 06:45 Sun link
Minera Panamá Requests Unblocking Access To Mine For Entry Of Environmental Supplies - menafn
MAIFF    - 5h ago link
Critical Survey: Pulmonx (NASDAQ:LUNG) versus Profound Medical (NASDAQ:PROF) - modernreaders
PROF    - 03:00 Sun link
Climate activists outnumbered by fossil fuel execs at Cop28 as space for protest shrinks - enviweb cz
FOSL    - 09:15 Sun link
Climate activists outnumbered by fossil fuel execs at Cop28 as space for protest shrinks - yahoo
FOSL    - 09:00 Sun link
Weight loss injections and suicide: Investigating the connection - jpost
LLY    - 20:00 Sun link
BNP Paribas Initiates Coverage on IDEXX Laboratories (NASDAQ:IDXX) - tickerreport
IDXX    - 12:45 Sun link
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease - joplinglobe
INCY    - 2h ago link
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis - valdostadailytimes
ALXN    - 54m ago link
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis - financialpost
PCDAF    - 3h ago link
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis - lelezard
ALXN    - 54m ago link
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis - joplinglobe
ALXN    - 2h ago link
Public meeting, safety plan, state oversight required before implosion of Springdale power plant - triblive
CHRA    - 2h ago link
Consumer product agency issues warning on small magnetic balls linked to deaths - netscape
NYT    - 08:30 Sun link
Consumer product agency issues warning on small magnetic balls linked to deaths - springfieldnewssun
NYT    - 02:15 Sun link
XRP Bulls on Alert as Analyst Signals Bullish Momentum, Targets $2 and Beyond - biztoc
GBTC    - 13:15 Sun link
Profound Medical (NASDAQ:PROF) versus Pulmonx (NASDAQ:LUNG) Head to Head Review - etfdailynews
PROF    - 03:15 Sun link
Contrasting Gossamer Bio (NASDAQ:GOSS) & ContraFect (NASDAQ:CFRX) - etfdailynews
CFRX    - 05:15 Sun link
EQS-News: MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study - businessinsider
MOR    - 2h ago link
Head-To-Head Analysis: Profound Medical (NASDAQ:PROF) vs. Hypertension Diagnostics (OTCMKTS:HDII) - dailypolitical
PROF    - 18:30 Sun link